Results

Total Results: 1,256 records

Showing results for "target".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
    January 01, 2023 - • Interventions designed to simultaneously target PTSD and comorbid conditions other than SUD if … SUD substance class and specific substance target 18.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
  3. effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
    September 27, 2012 - radiation therapy that delivers a high dose of radiation with high targeting accuracy to an extracranial target … Grading the Evidence for Each Key Question Selected studies will be assessed for relevance against target
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
    December 09, 2015 - The target populations are clearly defined. … Target audience and population were well-defined. Key Q were appropriate and adequately stated. … The target population and audience are clearly and explicitly described, as are the key questions. … No response required. 27 TEP Reviewer #5 General Comments The target population, audience, and … (the other target would be the traditional clinical symptom) that could be grounded in more basic
  6. M (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-de-novo-processes_methods.pdf
    September 01, 2009 - M Methods Guide for Comparative Effectiveness Reviews Using Existing Systematic Reviews To Replace De Novo Processes in Conducting Comparative Effectiveness Reviews Comparative Effectiveness Reviews are systematic reviews of existing research on the effectiveness, comparative effectiv…
  7. M (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/systematicreviewsreplacedenovo.pdf
    September 01, 2009 - M Methods Guide for Comparative Effectiveness Reviews Using Existing Systematic Reviews To Replace De Novo Processes in Conducting Comparative Effectiveness Reviews Comparative Effectiveness Reviews are systematic reviews of existing research on the effectiveness, comparative effectiv…
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
    November 13, 2014 - and the framework(s) underpinning an intervention determine its rationale.14 Interventions may also target
  9. effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
    March 21, 2016 - Section) does not enable to identify the target of aggressive behaviors. … that it is specifically the class of antipsychotics not all psychotropic medications that is the target … there is bias in this approach, still this is the common naturalistic mechanism for tracking these target … My overall rating of Good is with the assumption that the target audience is specific and expert in … The limits on defining the target population are inherent to the research in this area, not attributable
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/transitions-care-pediatric-to-adult-services-disposition-comments.pdf
    May 31, 2022 - Peer (TEP) Reviewer #7 General The authors do not explicitly identify a target audience for their … intended audience and have added this to the main points and background of the report stating: The target … Peer (TEP) Reviewer #8 General As for the target population, presumably the focus is on the pediatric … We highlight our target audience in the main points and background stating: The target audience for … The target populations are clearly defined, and I think the authors did a nice job of describing the
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hospital-length-of-stay-disposition-comments_0.pdf
    September 20, 2021 - represents an opportunity to decrease length of in hospital stay with interventions specifically target
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
    September 15, 2014 - The target population and audience for the report is explicitly stated. … studies making it difficult for a physician to make a clinical judgment regarding vitamin D intake and target … The target population is well defined. The key questions to be answered are very clear. … The goal in individual should not be to be greater than 50 or 70 nmol/L but rather these should be target
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
    February 01, 2013 - One nonrandomized study reported no statistical difference between groups in repeat target lesion revascularization … For the composite outcome of MACE (defined as death, MI, and target lesion revascularization) in this … The 1-year composite outcome of death, MI, and ischemia-driven target vessel revascularization was not … between groups for the clinical outcomes of mortality or MI, but found a significant difference in target
  14. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
    April 17, 2012 - The Healthcare Horizon Scanning System provides AHRQ a systematic process to identify and monitor target … technologies and innovations in health care and to create an inventory of target technologies that … pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary efficacy data on the target … adverse side effects could deter patients from opting for EndoBarrier treatment, others noted that the target
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-protocol.pdf
    April 19, 2023 - Trauma Informed Care Evidence-based Practice Center Systematic Review Protocol Project Title: Trauma Informed Care I. Background and Objectives for the Systematic Review Exposure to adverse and potentially traumatic experiences is common and may influence the health of millions of individuals. Trauma exp…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-204-obesity-disposition-comments.pdf
    December 01, 2017 - I do not recall that the authors explicitly defined the target population or audience. … strength and weakness, or for one particular survey instrument in terms of reliability, validity and target … For survey instrument’s, it will be nice to have a summary about their reliability, validity, target
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
    December 11, 2012 - The target population and key questions are properly defines. … Commentator & Affiliation Section Comment Response Peer Reviewer #6 General Comment The target … Peer Reviewer #6 General Comment The target audience is well characterized on page 43.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/childhood-cancer-disposition-comments.pdf
    February 16, 2022 - The target population and audience are explicitly defined and the key questions are appropriate and … The target population is clearly defined.
  19. effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
    July 09, 2013 - potential diffusion (e.g., in phase III trials or for which some preliminary efficacy data in the target … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central
  20. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - potential diffusion (e.g., in phase III trials or for which some preliminary efficacy data in the target … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: